Zacks: CHF Solutions Inc (CHFS) Receives Consensus Recommendation of “Strong Buy” from Analysts

CHF Solutions Inc (NASDAQ:CHFS) has earned an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.

Brokers have set a 1-year consensus target price of $5.70 for the company, according to Zacks. Zacks has also assigned CHF Solutions an industry rank of 121 out of 255 based on the ratings given to related companies.

A number of research analysts have recently commented on the company. Zacks Investment Research upgraded CHF Solutions from a “sell” rating to a “buy” rating and set a $1.75 price target for the company in a report on Tuesday, July 24th. ValuEngine upgraded CHF Solutions from a “hold” rating to a “buy” rating in a report on Monday, July 2nd.



CHFS traded down $0.09 on Friday, hitting $1.02. The company had a trading volume of 244,970 shares, compared to its average volume of 530,154. CHF Solutions has a 1-year low of $0.93 and a 1-year high of $24.45. The firm has a market cap of $7.46 million, a P/E ratio of -0.03 and a beta of 1.89.

CHF Solutions (NASDAQ:CHFS) last issued its quarterly earnings results on Tuesday, August 7th. The company reported ($0.93) EPS for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.01). CHF Solutions had a negative return on equity of 156.10% and a negative net margin of 471.94%. The business had revenue of $1.10 million for the quarter. research analysts expect that CHF Solutions will post -2.71 EPS for the current year.

In other news, CEO John L. Erb bought 23,584 shares of the business’s stock in a transaction that occurred on Tuesday, July 3rd. The stock was acquired at an average cost of $2.12 per share, for a total transaction of $49,998.08. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 3.50% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of CHFS. Perkins Capital Management Inc. acquired a new position in shares of CHF Solutions in the second quarter valued at $108,000. Dimensional Fund Advisors LP acquired a new position in shares of CHF Solutions in the second quarter valued at $161,000. Finally, Sabby Management LLC raised its stake in shares of CHF Solutions by 243.9% in the first quarter. Sabby Management LLC now owns 180,498 shares of the company’s stock valued at $504,000 after purchasing an additional 128,008 shares in the last quarter. Institutional investors and hedge funds own 3.22% of the company’s stock.

About CHF Solutions

CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.

Featured Article: Short Selling Stocks and Day Traders

Get a free copy of the Zacks research report on CHF Solutions (CHFS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CHF Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CHF Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Leave a Reply